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ABSTRACT
The goal of this research is to perform a preclinical evaluation of a non-Invasive medical monitoring device to predict blood loss and hemorrhage in humans. The aim Is to be able to detect subtle changes in hemodynamic variables that provide prodromal clues to Impend ing cardiovascular collapse. This will enhance the ability of first responders (medics), nurses, and physicians to intervene with appropriate resuscitative steps In Individuals who have suffered Injuries dunng combat. Since the last progress report we have studied a total of 12 subjects. These Individuals have been subjected to -15, -30, and -45 mmHg of lower body negative pressure (LBNP) and sequential blood loss of 333, 666, and 1 L total. Three abstracts related to this woi'K have been presented and two additional abstracts have been submitted for presentation, the high-resolution physiological records have been obtained for subsequent processing by machine teaming algorithms, and further off-line validation of the cardiovascular reserve index ( Blood was also drawn at selected time points to measure various markers of coagulation and also other hormonal measurements.
Key research accomplishments
To date we have completed the initial 12 studies. We have published 3 abstracts, submitted 2 additional abstracts, are currently conducting detailed analysis of the data with our collaborators in San Antonio, and beginning the generation of the relevant manuscripts.
Add itionally, we have identified key subject matter and hypotheses for follow-up studies that will begin in the fall of 2013.
Reportable Outcomes Figures 1 and 2 show the respective CVP and heart rate, changes associated with LBNP and blood loss in our subjects.
Although there are some differences in hemodynamics between LBNP and blood loss at corresponding stages (e.g. Figures 1 and 2), nearly all hemodynamic variables that we monitored appear to fall on similar trajectories throughout the attained ranges of CVP, regardless of protocol. Figure 3 is an example of how the heart rate responses fall on similar trajectories in each protocol throughout the attained CVP.
Conclusion
The last year has been highly successful and we have completed the main aims of the initial funding cycle. In general, the hemodynamic responses to LBNP and real blood loss were quite similar. There were
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Figw·e 2. HR is higher dwing LBNP vs. Blood Loss dwing the last two stages. 
